 Charles Robertson
Concepts (510)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 44 | 2024 | 724 | 3.730 |
Why?
| | Gastrointestinal Microbiome | 29 | 2025 | 641 | 2.590 |
Why?
| | RNA, Ribosomal, 16S | 45 | 2024 | 522 | 1.720 |
Why?
| | Bacteria | 31 | 2023 | 817 | 1.610 |
Why?
| | Otitis Media | 6 | 2025 | 160 | 0.970 |
Why?
| | Cystic Fibrosis | 12 | 2023 | 1049 | 0.920 |
Why?
| | Intestinal Mucosa | 10 | 2020 | 581 | 0.820 |
Why?
| | Feces | 16 | 2023 | 442 | 0.790 |
Why?
| | Intestines | 9 | 2017 | 344 | 0.770 |
Why?
| | Metagenome | 10 | 2019 | 140 | 0.750 |
Why?
| | Nasopharynx | 5 | 2024 | 67 | 0.690 |
Why?
| | Rhinitis | 6 | 2020 | 148 | 0.670 |
Why?
| | Biodiversity | 11 | 2020 | 377 | 0.670 |
Why?
| | Water Microbiology | 8 | 2018 | 85 | 0.650 |
Why?
| | Sinusitis | 6 | 2020 | 203 | 0.630 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 74 | 0.580 |
Why?
| | Phylogeny | 13 | 2020 | 849 | 0.550 |
Why?
| | Air Microbiology | 2 | 2015 | 40 | 0.530 |
Why?
| | Archaea | 2 | 2008 | 78 | 0.530 |
Why?
| | Ileum | 4 | 2020 | 116 | 0.500 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 775 | 0.500 |
Why?
| | RNA, Bacterial | 8 | 2018 | 183 | 0.450 |
Why?
| | Breast Feeding | 5 | 2023 | 422 | 0.440 |
Why?
| | Database Management Systems | 1 | 2013 | 48 | 0.420 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.420 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.420 |
Why?
| | User-Computer Interface | 1 | 2013 | 148 | 0.400 |
Why?
| | Aerosols | 1 | 2013 | 168 | 0.390 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 99 | 0.380 |
Why?
| | Geologic Sediments | 2 | 2008 | 41 | 0.380 |
Why?
| | Trachea | 4 | 2023 | 221 | 0.380 |
Why?
| | HIV Infections | 5 | 2025 | 2711 | 0.360 |
Why?
| | Crohn Disease | 4 | 2020 | 216 | 0.350 |
Why?
| | Colon | 3 | 2023 | 252 | 0.350 |
Why?
| | Fucosyltransferases | 2 | 2022 | 32 | 0.340 |
Why?
| | Lung | 7 | 2021 | 3748 | 0.330 |
Why?
| | Arthritis, Experimental | 2 | 2023 | 128 | 0.330 |
Why?
| | Dysbiosis | 5 | 2023 | 167 | 0.330 |
Why?
| | Inflammation | 10 | 2022 | 2666 | 0.320 |
Why?
| | DNA, Bacterial | 8 | 2021 | 324 | 0.320 |
Why?
| | Humans | 78 | 2025 | 128495 | 0.320 |
Why?
| | Software | 1 | 2013 | 608 | 0.300 |
Why?
| | Genes, rRNA | 5 | 2015 | 41 | 0.300 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 258 | 0.290 |
Why?
| | Male | 52 | 2025 | 63043 | 0.290 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 163 | 0.290 |
Why?
| | Case-Control Studies | 15 | 2020 | 3339 | 0.290 |
Why?
| | Female | 53 | 2025 | 68266 | 0.280 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 8 | 0.270 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2021 | 624 | 0.270 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 205 | 0.260 |
Why?
| | Legionella | 2 | 2017 | 7 | 0.260 |
Why?
| | HIV-1 | 2 | 2024 | 834 | 0.250 |
Why?
| | Dietary Supplements | 3 | 2019 | 531 | 0.250 |
Why?
| | Fatty Liver | 2 | 2021 | 231 | 0.250 |
Why?
| | Drinking Water | 3 | 2017 | 75 | 0.250 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 178 | 0.250 |
Why?
| | Mice | 21 | 2025 | 16620 | 0.250 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2822 | 0.250 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 218 | 0.250 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 33 | 0.250 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 57 | 0.250 |
Why?
| | Animals | 30 | 2025 | 34647 | 0.240 |
Why?
| | Environmental Microbiology | 1 | 2005 | 48 | 0.240 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 318 | 0.240 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 119 | 0.240 |
Why?
| | Drug Resistance | 2 | 2017 | 165 | 0.240 |
Why?
| | Ear, Middle | 5 | 2025 | 91 | 0.230 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 159 | 0.230 |
Why?
| | Construction Materials | 2 | 2015 | 13 | 0.230 |
Why?
| | Metagenomics | 3 | 2019 | 156 | 0.230 |
Why?
| | Adult | 30 | 2025 | 35299 | 0.230 |
Why?
| | Bacteremia | 2 | 2018 | 197 | 0.230 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2017 | 487 | 0.230 |
Why?
| | Liver | 3 | 2020 | 1827 | 0.220 |
Why?
| | Ecosystem | 2 | 2007 | 566 | 0.220 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 436 | 0.220 |
Why?
| | Child | 22 | 2025 | 20805 | 0.220 |
Why?
| | Infant Formula | 2 | 2023 | 74 | 0.220 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3626 | 0.220 |
Why?
| | Sputum | 5 | 2020 | 301 | 0.220 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 372 | 0.220 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 518 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 110 | 0.210 |
Why?
| | Respiratory System | 2 | 2016 | 152 | 0.210 |
Why?
| | Diet, Western | 2 | 2022 | 79 | 0.210 |
Why?
| | Premature Birth | 3 | 2017 | 310 | 0.210 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 529 | 0.210 |
Why?
| | Milk, Human | 3 | 2023 | 149 | 0.210 |
Why?
| | Alternative Splicing | 1 | 2025 | 216 | 0.200 |
Why?
| | Iron | 2 | 2016 | 282 | 0.200 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 320 | 0.200 |
Why?
| | Staphylococcus | 4 | 2017 | 74 | 0.200 |
Why?
| | Mice, Inbred C57BL | 12 | 2022 | 5281 | 0.200 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1088 | 0.200 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.200 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1705 | 0.200 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 183 | 0.200 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 194 | 0.190 |
Why?
| | Cholesteatoma | 1 | 2022 | 11 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 366 | 0.190 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 371 | 0.190 |
Why?
| | Haemophilus Infections | 1 | 2022 | 39 | 0.190 |
Why?
| | Transcriptome | 3 | 2021 | 883 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 175 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 11 | 0.180 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 5045 | 0.180 |
Why?
| | Colitis | 2 | 2020 | 240 | 0.180 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 392 | 0.180 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.170 |
Why?
| | Oropharynx | 2 | 2024 | 43 | 0.170 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 47 | 0.170 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.170 |
Why?
| | Infant | 11 | 2025 | 9001 | 0.170 |
Why?
| | Perilipin-2 | 2 | 2017 | 36 | 0.170 |
Why?
| | Groundwater | 1 | 2020 | 37 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Nasal Polyps | 1 | 2020 | 57 | 0.170 |
Why?
| | Mucin 5AC | 1 | 2020 | 69 | 0.170 |
Why?
| | Hot Springs | 2 | 2012 | 7 | 0.170 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.170 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 229 | 0.170 |
Why?
| | Birth Weight | 2 | 2020 | 499 | 0.170 |
Why?
| | Middle Aged | 21 | 2024 | 30921 | 0.170 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 162 | 0.160 |
Why?
| | Respiratory System Agents | 1 | 2020 | 22 | 0.160 |
Why?
| | Adolescent | 18 | 2021 | 20304 | 0.160 |
Why?
| | Biofilms | 3 | 2017 | 243 | 0.160 |
Why?
| | Inflammation Mediators | 2 | 2020 | 498 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 19 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 138 | 0.160 |
Why?
| | Burns | 1 | 2023 | 284 | 0.160 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 377 | 0.160 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1027 | 0.160 |
Why?
| | Esomeprazole | 1 | 2018 | 6 | 0.160 |
Why?
| | Chronic Disease | 7 | 2022 | 1692 | 0.160 |
Why?
| | Vitamin B Complex | 1 | 2019 | 41 | 0.160 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 169 | 0.150 |
Why?
| | Diet, High-Fat | 2 | 2017 | 238 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 5 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2269 | 0.150 |
Why?
| | Body Mass Index | 4 | 2020 | 2263 | 0.150 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 238 | 0.150 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 8 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 122 | 0.150 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 14 | 0.150 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 14 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Chloramines | 2 | 2015 | 11 | 0.150 |
Why?
| | Quinolones | 1 | 2020 | 126 | 0.150 |
Why?
| | Aminophenols | 1 | 2020 | 144 | 0.150 |
Why?
| | Probiotics | 1 | 2018 | 51 | 0.150 |
Why?
| | Asthma | 3 | 2017 | 2213 | 0.140 |
Why?
| | Infant, Newborn | 8 | 2025 | 5740 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 45 | 0.140 |
Why?
| | Immunity, Innate | 3 | 2019 | 803 | 0.140 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 9 | 0.140 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 428 | 0.140 |
Why?
| | Infant Nutritional Physiological Phenomena | 2 | 2023 | 137 | 0.140 |
Why?
| | Clostridium Infections | 1 | 2018 | 62 | 0.140 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.140 |
Why?
| | Child, Preschool | 9 | 2025 | 10487 | 0.130 |
Why?
| | Sepsis | 1 | 2023 | 569 | 0.130 |
Why?
| | Disease Models, Animal | 7 | 2022 | 3947 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 471 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 533 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 338 | 0.130 |
Why?
| | Respiration, Artificial | 3 | 2023 | 604 | 0.130 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 308 | 0.130 |
Why?
| | Lipid Metabolism | 2 | 2020 | 492 | 0.130 |
Why?
| | Pharynx | 1 | 2016 | 57 | 0.130 |
Why?
| | Pedigree | 3 | 2025 | 485 | 0.130 |
Why?
| | Young Adult | 11 | 2021 | 12349 | 0.130 |
Why?
| | Vitamin E | 1 | 2016 | 120 | 0.130 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 15 | 0.130 |
Why?
| | Rivers | 1 | 2016 | 66 | 0.130 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 7 | 0.130 |
Why?
| | Biomarkers | 5 | 2020 | 3893 | 0.130 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 74 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 57 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 301 | 0.120 |
Why?
| | Lactobacillus | 3 | 2022 | 26 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.120 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 137 | 0.120 |
Why?
| | Base Sequence | 3 | 2015 | 2137 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 33 | 0.120 |
Why?
| | Nose | 1 | 2015 | 64 | 0.120 |
Why?
| | Bronchi | 1 | 2016 | 241 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 63 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 80 | 0.120 |
Why?
| | Prospective Studies | 7 | 2022 | 7069 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Biota | 1 | 2015 | 35 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 218 | 0.120 |
Why?
| | Household Articles | 1 | 2014 | 24 | 0.120 |
Why?
| | Humidity | 1 | 2014 | 49 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 215 | 0.120 |
Why?
| | Rats | 6 | 2023 | 5246 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 564 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 101 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 564 | 0.110 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 61 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 140 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 42 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 26 | 0.110 |
Why?
| | Aged | 11 | 2023 | 21974 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 32 | 0.110 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 46 | 0.110 |
Why?
| | Age Factors | 2 | 2019 | 3122 | 0.110 |
Why?
| | Hippocampus | 1 | 2018 | 832 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 751 | 0.110 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 83 | 0.110 |
Why?
| | Nasal Cavity | 1 | 2013 | 50 | 0.110 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 104 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 935 | 0.110 |
Why?
| | Computational Biology | 2 | 2019 | 597 | 0.110 |
Why?
| | Cities | 1 | 2013 | 105 | 0.110 |
Why?
| | Saliva | 1 | 2015 | 210 | 0.110 |
Why?
| | Bacteroidetes | 3 | 2021 | 23 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 205 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 95 | 0.100 |
Why?
| | New York City | 1 | 2013 | 80 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1464 | 0.100 |
Why?
| | Iron, Dietary | 1 | 2013 | 21 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 570 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2019 | 1109 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 107 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 545 | 0.100 |
Why?
| | Prednisone | 1 | 2013 | 230 | 0.100 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 230 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 324 | 0.100 |
Why?
| | Pregnancy | 6 | 2025 | 6373 | 0.100 |
Why?
| | Infant Food | 1 | 2013 | 65 | 0.100 |
Why?
| | Seawater | 1 | 2012 | 26 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2014 | 235 | 0.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 222 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Mexico | 2 | 2012 | 190 | 0.100 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 245 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 29 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 258 | 0.100 |
Why?
| | Body Fluids | 1 | 2012 | 62 | 0.100 |
Why?
| | Bacterial Translocation | 1 | 2012 | 40 | 0.100 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 129 | 0.090 |
Why?
| | Islets of Langerhans | 2 | 2015 | 790 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 37 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1310 | 0.090 |
Why?
| | Mice, Knockout | 4 | 2022 | 2765 | 0.090 |
Why?
| | Cytokines | 2 | 2018 | 1994 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 240 | 0.090 |
Why?
| | Autoimmunity | 2 | 2015 | 860 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2018 | 1064 | 0.090 |
Why?
| | Esophagus | 1 | 2012 | 248 | 0.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 395 | 0.080 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 385 | 0.080 |
Why?
| | Indoles | 1 | 2013 | 372 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 2864 | 0.080 |
Why?
| | Phenotype | 5 | 2020 | 3051 | 0.080 |
Why?
| | Genes, Bacterial | 3 | 2018 | 158 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 77 | 0.080 |
Why?
| | Cohort Studies | 5 | 2019 | 5402 | 0.080 |
Why?
| | Genotype | 4 | 2019 | 1830 | 0.080 |
Why?
| | Cholesterol | 2 | 2022 | 406 | 0.080 |
Why?
| | Pacific Ocean | 1 | 2008 | 6 | 0.080 |
Why?
| | Weight Loss | 1 | 2014 | 727 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 344 | 0.080 |
Why?
| | RNA, Archaeal | 1 | 2008 | 16 | 0.080 |
Why?
| | DNA, Archaeal | 1 | 2008 | 15 | 0.080 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 150 | 0.080 |
Why?
| | Firmicutes | 2 | 2021 | 18 | 0.080 |
Why?
| | Exome | 2 | 2020 | 220 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2433 | 0.070 |
Why?
| | Smoke | 2 | 2023 | 131 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 722 | 0.070 |
Why?
| | Methane | 2 | 2020 | 49 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 66 | 0.070 |
Why?
| | Fatty Acids | 2 | 2022 | 417 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 622 | 0.070 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 10 | 0.070 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 58 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 953 | 0.070 |
Why?
| | Freezing | 1 | 2007 | 86 | 0.070 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 13 | 0.070 |
Why?
| | Equipment Contamination | 2 | 2017 | 56 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 941 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2010 | 732 | 0.060 |
Why?
| | Genes, Archaeal | 1 | 2005 | 6 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2020 | 332 | 0.060 |
Why?
| | Cryopreservation | 1 | 2007 | 97 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 182 | 0.060 |
Why?
| | Insulin | 1 | 2016 | 2316 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 996 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 92 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 644 | 0.060 |
Why?
| | Water Purification | 2 | 2017 | 146 | 0.060 |
Why?
| | Treatment Outcome | 5 | 2020 | 10162 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2516 | 0.060 |
Why?
| | Disinfection | 2 | 2017 | 115 | 0.060 |
Why?
| | Gestational Age | 2 | 2017 | 871 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2018 | 2679 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7057 | 0.050 |
Why?
| | Administration, Oral | 2 | 2019 | 767 | 0.050 |
Why?
| | Tobramycin | 1 | 2023 | 51 | 0.050 |
Why?
| | Geography | 2 | 2014 | 188 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 107 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 541 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2463 | 0.050 |
Why?
| | Colorado | 3 | 2020 | 4399 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1499 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 92 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 38 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1192 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 52 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 816 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 47 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 75 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 171 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 222 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2624 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1142 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 8 | 0.050 |
Why?
| | Water | 2 | 2018 | 442 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 255 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2023 | 661 | 0.050 |
Why?
| | Endoscopy | 2 | 2015 | 271 | 0.050 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 51 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 198 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2710 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 430 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 617 | 0.050 |
Why?
| | Aerobiosis | 1 | 2020 | 22 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1938 | 0.040 |
Why?
| | Bacterial Proteins | 2 | 2018 | 833 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 205 | 0.040 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 586 | 0.040 |
Why?
| | Smoking | 2 | 2020 | 1459 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 637 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 764 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 31 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 91 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 80 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 213 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2741 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 513 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 46 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 117 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 356 | 0.040 |
Why?
| | Diet | 2 | 2019 | 1204 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 118 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 9 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 67 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 51 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 186 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 511 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 47 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2020 | 315 | 0.040 |
Why?
| | Risk Factors | 3 | 2017 | 9737 | 0.040 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 96 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 344 | 0.040 |
Why?
| | Prognosis | 2 | 2020 | 3780 | 0.040 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 36 | 0.040 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 94 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 14 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 40 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 443 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 67 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 106 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 160 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 398 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 60 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 195 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 755 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1227 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 88 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 74 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 606 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 58 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 175 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 312 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 26 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 153 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3387 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 15 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 683 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 107 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 250 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 735 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 9 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 639 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 9 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 185 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 128 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 169 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 982 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 80 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 29 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 28 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 107 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 107 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 60 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 509 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 39 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 20 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 29 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 15 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1394 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 48 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 41 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 207 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 156 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 49 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 116 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 175 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 89 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 466 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 254 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 94 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1951 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 150 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 31 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 61 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 479 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 313 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2064 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 144 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1455 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 87 | 0.030 |
Why?
| | Connectome | 1 | 2014 | 84 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 312 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1568 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 498 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 402 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1755 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 41 | 0.030 |
Why?
| | DNA, Viral | 1 | 2014 | 348 | 0.030 |
Why?
| | Genetic Markers | 1 | 2013 | 338 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 362 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 279 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 538 | 0.030 |
Why?
| | Neural Pathways | 1 | 2014 | 297 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 359 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 282 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.020 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 40 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 58 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1191 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 88 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 58 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2719 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2016 | 1856 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 77 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 55 | 0.020 |
Why?
| | Suction | 1 | 2011 | 32 | 0.020 |
Why?
| | Skin | 1 | 2016 | 717 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 470 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 134 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 324 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 580 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4874 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 933 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2092 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 229 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1043 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 515 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 177 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 41 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 375 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 326 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 504 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 757 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2604 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 450 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 281 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 593 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4017 | 0.020 |
Why?
| | Risk | 1 | 2011 | 853 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3696 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1079 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1689 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 771 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Mining | 1 | 2007 | 17 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1464 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1346 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 915 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 2069 | 0.020 |
Why?
| | Temperature | 1 | 2007 | 632 | 0.010 |
Why?
| | United States | 1 | 2015 | 13840 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 14471 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|